<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://openbell.ai/</loc>
    <lastmod>2026-09-21T11:29:53.712Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://openbell.ai/support</loc>
    <lastmod>2026-09-21T11:29:53.712Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://openbell.ai/privacy</loc>
    <lastmod>2026-09-21T11:29:53.712Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/terms</loc>
    <lastmod>2026-09-21T11:29:53.712Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/feed.json</loc>
    <lastmod>2026-09-21T11:29:53.712Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://openbell.ai/news/NSANY:1789990187388</loc>
    <lastmod>2026-09-21T11:29:47.388Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NSANY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>&amp;#39;Nissan eyes increasing U.S. production as new Rogue hybrid launches&amp;#39; - CNBC</image:title>
      <image:caption>Nissan plans to increase its U.S. production capacity with the launch of the new Rogue hybrid model. This strategic move aims to meet growing demand for hybrid vehicles in the American market. The company is focusing on enhancing its manufacturing capabilities to support this initiative, which could positively impact its market position and sales figures.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/QUIK:1789990140946</loc>
    <lastmod>2026-09-21T11:29:00.946Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/QUIK/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>QuickLogic Affirms FY2026 Sales Guidance of $23.416M-$24.793M vs $24.357M Est; Sees Full-Year Growth Of 70%-80%.</image:title>
      <image:caption>QuickLogic (NASDAQ: QUIK) has reaffirmed its sales guidance for FY2026, projecting revenues between $23.416 million and $24.793 million, compared to an estimated $24.357 million. The company anticipates a full-year growth rate of 70% to 80%.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/JPM:1789990042783</loc>
    <lastmod>2026-09-21T11:27:22.783Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/JPM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>&amp;#39;JPMorgan, Qatar’s QIA Target $20 Billion Investment Partnership&amp;#39; - Bloomberg</image:title>
      <image:caption>JPMorgan Chase and Qatar&#39;s sovereign wealth fund, Qatar Investment Authority (QIA), are aiming to establish a $20 billion investment partnership. This collaboration is expected to focus on various sectors, enhancing both parties&#39; investment portfolios. The partnership reflects a strategic move to leverage Qatar&#39;s financial resources and JPMorgan&#39;s investment expertise.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ACN:1789989992558</loc>
    <lastmod>2026-09-21T11:26:32.558Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ACN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Market-Moving News for September 21st</image:title>
      <image:caption>Accenture (ACN) shares rose by 8% following the announcement of a partnership to create a team of embedded evaluators at Anthropic. This strategic move is expected to enhance Accenture&#39;s capabilities in the AI sector. The article also mentions significant stock movements for Greenland Energy, which saw a 165% increase due to a US-Greenland agreement, and a 30% drop in CRML related to reduced Chinese rare earth shipments to the US.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/PRTH:1789989900615</loc>
    <lastmod>2026-09-21T11:25:00.615Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PRTH/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Trading Halt: Halted at 7:25:00 a.m. ET - Trading Halt: Halt News Pending</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MU:1789989336306</loc>
    <lastmod>2026-09-21T11:15:36.306Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/21/Micron-MU-Logo-On-Smartphone-With-Semico.jpg?width=250&amp;height=187</image:loc>
      <image:title>Micron Stock Soars 517% in a Year, Jim Cramer Still Calls It ‘Incredibly Cheap’</image:title>
      <image:caption>Micron Technology Inc. (NASDAQ: MU) stock has surged 517% over the past year and rose 2.24% to $1,038.51 in premarket trading. The company is set to report earnings on September 30, with Wall Street expecting earnings of $31.33 per share on revenue of $50.95 billion, a significant increase from $3.03 per share and $11.31 billion in the previous year. Analyst Jim Cramer noted that Micron&#39;s valuation remains attractive, trading at about 13 times earnings, and highlighted strong demand for high-bandwidth memory used in AI systems.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ODFL:1789989167983</loc>
    <lastmod>2026-09-21T11:12:47.983Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ODFL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Old Dominion Freight Line Raises Shipping Rates 4.9% Starting Oct. 5</image:title>
      <image:caption>Old Dominion Freight Line, Inc. (NASDAQ: ODFL) has announced a general rate increase of 4.9% effective October 5, 2026, impacting rates under the existing ODFL 559, 670, and 550 tariffs. The increase may vary by customer based on specific shipment lanes and distances, and it will also include a nominal rise in minimum charges for intrastate, interstate, and cross-border shipments.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CRML:1789989162764</loc>
    <lastmod>2026-09-21T11:12:42.764Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/21/Tensions-Escalate-Between-the-US-and-EU.jpg?width=250&amp;height=187</image:loc>
      <image:title>Why Is Critical Metals Stock Soaring Monday?</image:title>
      <image:caption>Critical Metals Corp. (NASDAQ: CRML) saw its stock price increase by approximately 27% to $8.55 in premarket trading following a U.S.-Denmark agreement that grants the U.S. permanent control over Greenland&#39;s security, highlighting the strategic importance of the island&#39;s mineral resources. The company is developing the Tanbreez rare earth project in Greenland, which has attracted investor interest amid growing demand for minerals critical to national security. Other companies linked to Greenland also experienced stock price increases as the market reacted to the potential for increased U.S. involvement in mining and infrastructure on the island.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/VEEV:1789989094057</loc>
    <lastmod>2026-09-21T11:11:34.057Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VEEV/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Veeva Launches AI Agent To Speed Up Safety And Medical Request Routing</image:title>
      <image:caption>Veeva Systems (NYSE: VEEV) has launched Veeva Falcon Router, an AI-driven agent designed to enhance the routing of safety adverse event reports, product quality complaints, and medical inquiries for biopharmaceutical companies. The Falcon Router will streamline triage and routing processes, focusing initially on email and web intake, and will integrate with Veeva Safety, Veeva QMS, and Veeva MedInquiry, eliminating the need for manual reconciliation.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SCNI:1789989077061</loc>
    <lastmod>2026-09-21T11:11:17.061Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SCNI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Scinai Immunotherapeutics Regains Nasdaq Compliance</image:title>
      <image:caption>Scinai Immunotherapeutics Ltd (NASDAQ: SCNI) has regained compliance with Nasdaq Listing Rule 5550(a)(2) after maintaining a closing bid price at or above $1.00 for 19 consecutive business days. Nasdaq has confirmed that the minimum bid price issue is now resolved.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/INSM:1789989029323</loc>
    <lastmod>2026-09-21T11:10:29.323Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/INSM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>The FDA Accepts Insmed&amp;#39;s Supplemental New Drug Application For Review Of Arikayce (Amikacin Liposome Inhalation Suspension) For Mycobacterium Avium Complex Lung Disease As Part Of Combination Antibacterial Drug Regimen, With Target Action Date Of January 28, 2027</image:title>
      <image:caption>Insmed Incorporated announced that the FDA has accepted its Supplemental New Drug Application (sNDA) for ARIKAYCE (amikacin liposome inhalation suspension) to treat Mycobacterium avium complex lung disease, with a target action date of January 28, 2027. The FDA granted Priority Review for this application, indicating it could significantly improve treatment for this serious condition. The sNDA is supported by positive results from the Phase 3b ENCORE study, which demonstrated significant improvements in respiratory symptoms and culture conversion when ARIKAYCE was used in combination with multidrug therapy. Insmed also plans to engage with the Pharmaceuticals and Medical Devices Agency in Japan for potential label expansion in late 2026.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ATEX:1789989026914</loc>
    <lastmod>2026-09-21T11:10:26.914Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ATEX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Anterix Says iPhone 18 Pro And iPhone Duo Are First iPhone Models To Operate On Dedicated Private LTE Networks Using Anterix 900 MHz Spectrum</image:title>
      <image:caption>Anterix (NASDAQ: ATEX) announced that the iPhone 18 Pro and iPhone Duo are the first iPhone models to utilize dedicated private LTE networks on Anterix&#39;s 900 MHz spectrum. This development allows critical infrastructure operators to enhance field communications and operational applications using these new devices on band 106 licensed 900 MHz spectrum.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/PGEN:1789988998609</loc>
    <lastmod>2026-09-21T11:09:58.609Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PGEN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Precigen Says FDA Granted Platform Technology Designation To AdenoVerse Immunotherapy Platform</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/WAT:1789988987027</loc>
    <lastmod>2026-09-21T11:09:47.027Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/WAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Goldman Sachs Maintains Buy on Waters, Raises Price Target to $515</image:title>
      <image:caption>Goldman Sachs analyst Evie Koslosky has reaffirmed a Buy rating on Waters Corporation (NYSE: WAT) and increased the price target from $465 to $515. This adjustment reflects a positive outlook for the company&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TEAM:1789988983759</loc>
    <lastmod>2026-09-21T11:09:43.759Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TEAM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Cantor Fitzgerald Maintains Overweight on Atlassian, Raises Price Target to $220</image:title>
      <image:caption>Cantor Fitzgerald analyst Thomas Blakey has maintained an Overweight rating on Atlassian (NASDAQ: TEAM) and raised the price target from $175 to $220. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/OMC:1789988956299</loc>
    <lastmod>2026-09-21T11:09:16.299Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OMC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Omnicom Media Awarded $3.3B In New Billings In H1 2026</image:title>
      <image:caption>Omnicom Media was awarded $3.3 billion in new billings in the first half of 2026, leading among global media management groups. The total new business performance, defined as wins minus losses, amounted to $3.15 billion, placing Omnicom Media in a close competition for the top position in global media rankings. This strong performance reflects marketers&#39; ongoing evaluation of agency partners based on their capabilities in data, analytics, AI, and technology.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ARMP:1789988936772</loc>
    <lastmod>2026-09-21T11:08:56.772Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ARMP/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Armata Pharmaceuticals Says Lab Data Show Genetic Diversity In AP-SA02 May Enhance Killing Of Certain Staph Strains</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NOW:1789988934549</loc>
    <lastmod>2026-09-21T11:08:54.549Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NOW/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Cantor Fitzgerald Maintains Overweight on ServiceNow, Raises Price Target to $174</image:title>
      <image:caption>Cantor Fitzgerald analyst Thomas Blakey has maintained an Overweight rating on ServiceNow (NYSE: NOW) and raised the price target from $141 to $174. This adjustment reflects a positive outlook for the company&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SCNI:1789988916370</loc>
    <lastmod>2026-09-21T11:08:36.370Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SCNI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Scinai Immunotherapeutics Says It Received Nasdaq Notice Confirming Regained Compliance With Minimum Bid Price Rule</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BRKR:1789988888361</loc>
    <lastmod>2026-09-21T11:08:08.361Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BRKR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Bruker Wins Major UC Berkeley Order For Advanced Research Systems</image:title>
      <image:caption>Bruker Corporation (NASDAQ: BRKR) has secured a multi-system order from the University of California, Berkeley for advanced high-field Nuclear Magnetic Resonance (NMR) instrumentation at the Pines Magnetic Resonance Center. This order includes a Bruker AV NEO-X 800 MHz spectrometer and several additional NMR systems, aimed at enhancing research capabilities in chemistry, materials science, and structural biology. The investment will provide 24/7 access to cutting-edge NMR technologies for researchers across academia and national laboratories.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MSFT:1789988875322</loc>
    <lastmod>2026-09-21T11:07:55.322Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Cantor Fitzgerald Maintains Overweight on Microsoft, Raises Price Target to $608</image:title>
      <image:caption>Cantor Fitzgerald analyst Thomas Blakey has maintained an Overweight rating on Microsoft (NASDAQ: MSFT) and raised the price target from $522 to $608. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MX:1789988866563</loc>
    <lastmod>2026-09-21T11:07:46.563Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Navitas Semiconductor Agrees To Make $5M Strategic Equity Investment In Magnachip</image:title>
      <image:caption>Navitas Semiconductor Corporation has agreed to make a $5 million strategic equity investment in Magnachip Semiconductor Corporation. Magnachip will issue 1,461,988 shares of its common stock to Navitas at a price of $3.42 per share, with the transaction expected to close around September 24, 2026. This investment strengthens the partnership between the two companies, which aims to accelerate the adoption of silicon carbide technologies in power markets.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NUAI:1789988862126</loc>
    <lastmod>2026-09-21T11:07:42.126Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NUAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>New Era Energy &amp;amp; Digital Announces 20-Year, 200-207 MW Power Purchase Agreement With Vistra&amp;#39;s Luminant For Texas Data Center Phase 1</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/FIVN:1789988812036</loc>
    <lastmod>2026-09-21T11:06:52.036Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FIVN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Cantor Fitzgerald Maintains Overweight on Five9, Raises Price Target to $40</image:title>
      <image:caption>Cantor Fitzgerald analyst Thomas Blakey has maintained an Overweight rating on Five9 (NASDAQ: FIVN) and raised the price target from $34 to $40. This adjustment reflects a positive outlook for the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TLSA:1789988805309</loc>
    <lastmod>2026-09-21T11:06:45.309Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TLSA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Tiziana Completes Phase 2a MS Trial, Topline Data Due In October</image:title>
      <image:caption>Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) has completed its Phase 2a clinical trial for intranasal foralumab in patients with non-active Secondary Progressive Multiple Sclerosis, enrolling 48 patients across multiple U.S. sites. The trial, known as INFORM-MS, evaluated safety, tolerability, and efficacy over a 12-week period, with topline data expected to be announced in October. Following the trial, participants will have the opportunity to receive intranasal foralumab in a six-month open-label extension to gather longer-term safety and efficacy data.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ALKS:1789988800724</loc>
    <lastmod>2026-09-21T11:06:40.724Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ALKS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Alkermes Shares Topline Results From Phase 1 Proof-of-concept Study Evaluating ALKS 7290 For Attention-deficit Hyperactivity Disorder, Showing Meaningful Improvements In Patients</image:title>
      <image:caption>Alkermes plc (NASDAQ: ALKS) announced positive topline results from a Phase 1 proof-of-concept study for ALKS 7290, an investigational orexin 2 receptor agonist aimed at treating ADHD. The study involved 50 adults with ADHD and showed clinically meaningful improvements in ADHD symptoms as measured by the Adult ADHD Investigator Symptom Rating Scale (AISRS) and Clinical Global Impression-Severity Scale (CGI-S) after 14 days of treatment. ALKS 7290 was generally well tolerated, with no serious adverse events reported, and the company plans to advance to a Phase 2 study to further evaluate its efficacy and safety.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BRR:1789988730219</loc>
    <lastmod>2026-09-21T11:05:30.219Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BRR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>ProCap Says Its AI Beats Top Models On Tax, Mortgage And Credit Card Questions</image:title>
      <image:caption>ProCap Financial, Inc. (NASDAQ: BRR) announced that its AI agent, Silvia, has outperformed leading AI models in personal finance areas such as tax, mortgage, and credit cards. The company rebuilt Silvia&#39;s technology stack to enhance performance, resulting in a 48% reduction in median response time and a 59% decrease in cost per question since the new model&#39;s rollout in July. Additionally, the proportion of negatively rated answers has decreased by over 50%, while monthly active users have increased significantly since March.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MPC:1789988613305</loc>
    <lastmod>2026-09-21T11:03:33.305Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MPC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Goldman Sachs Maintains Buy on Marathon Petroleum, Raises Price Target to $472</image:title>
      <image:caption>Goldman Sachs analyst Neil Mehta has reaffirmed a Buy rating on Marathon Petroleum (NYSE: MPC) and increased the price target from $376 to $472. This adjustment reflects a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/WBD:1789988557378</loc>
    <lastmod>2026-09-21T11:02:37.378Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/WBD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Paramount Reportedly Nears California AG Deal to Clear WBD Merger Hurdle, Weighs $1.5 Billion Investment — PSKY, WBD Surge Over 7% (UPDATED)</image:title>
      <image:caption>Paramount Skydance Corp. is reportedly in advanced settlement talks with California&#39;s attorney general regarding its $110 billion acquisition of Warner Bros. Discovery, which includes a potential $1.5 billion investment in California&#39;s film and television production. Shares of both Paramount Skydance and Warner Bros. Discovery surged by 7.30% during pre-market trading. The negotiations also involve commitments to retain studio lots in California and potentially face penalties if Paramount does not produce 30 movies annually post-merger. The merger has faced delays due to antitrust challenges, with a federal trial scheduled for March 2027.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/KGS:1789988501372</loc>
    <lastmod>2026-09-21T11:01:41.372Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/KGS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Kodiak Gas Services Enters Into Agreement To Provide 76 Megawatts Of Behind-The-Meter, Baseload Power Capacity To West Texas Data Center For Term Of Six Years</image:title>
      <image:caption>Kodiak Gas Services, Inc. (NYSE: KGS) has entered into a six-year agreement to provide 76 megawatts of behind-the-meter, baseload power capacity to a West Texas data center. The company will deploy approximately 40 natural gas-fueled generation units, with deployment expected to begin in Q4 2026 and revenue recognition anticipated in Q1 2027.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/XRN:1789988476192</loc>
    <lastmod>2026-09-21T11:01:16.192Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/XRN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Cantor Fitzgerald Initiates Coverage On Chiron Real Estate with Overweight Rating, Announces Price Target of $43</image:title>
      <image:caption>Cantor Fitzgerald has initiated coverage on Chiron Real Estate (NYSE: XRN) with an Overweight rating. The firm has set a price target of $43 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/USO:1789988421821</loc>
    <lastmod>2026-09-21T11:00:21.821Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/21/Persons-Hand-Holding-A-Fuel-Nozzle--Inse.jpg?width=250&amp;height=187</image:loc>
      <image:title>Diesel Hits Record $6.51 a Gallon as Fuel Crisis Deepens: Commodity Strategist Warns ‘No Handshake Can Refill’ the Market</image:title>
      <image:caption>The national average price for diesel reached a record high of $6.51 per gallon, significantly impacting the agricultural and logistics sectors by increasing farm fuel costs by $11 per acre for corn and $7 per acre for soybeans compared to last year. Supply disruptions, including compromised crude oil export routes and refinery shortages, have exacerbated the situation, with Brent crude futures hitting $101.60 per barrel. The ongoing fuel crisis poses a threat to independent trucking firms, potentially leading to bankruptcies.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/USO:1789988405092</loc>
    <lastmod>2026-09-21T11:00:05.092Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Diesel Hits Historic $6.51/Gal: Commodity Strategist Warns We Are Facing a Deficit That &amp;#39;No Handshake&amp;#39; Can Refill</image:title>
      <image:caption>The national average price for diesel reached a historic high of $6.51 per gallon, significantly impacting the agricultural and logistics sectors, with farm fuel costs increasing by $11 per acre for corn and $7 per acre for soybeans compared to last year. The supply disruption is attributed to geopolitical tensions and refinery shortages, with Brent crude futures also rising to $101.60 per barrel. Analysts warn that these conditions could lead to increased bankruptcies among independent trucking firms due to the soaring fuel prices.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SECZ:1789988384501</loc>
    <lastmod>2026-09-21T10:59:44.501Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SECZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Cantor Fitzgerald Initiates Coverage On Securitize Holdings with Overweight Rating, Announces Price Target of $21.2</image:title>
      <image:caption>Cantor Fitzgerald has initiated coverage on Securitize Holdings (NYSE: SECZ) with an Overweight rating. The firm has set a price target of $21.2 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NVO:1789988332452</loc>
    <lastmod>2026-09-21T10:58:52.452Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NVO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Novo Nordisk Releases Topline Results From Phase 3 REIMAGINE 5 and REDEFINE 9 Trials Of Once-Weekly Cagrisema (Cagrilintide and Semaglutide)</image:title>
      <image:caption>Novo Nordisk announced topline results from its phase 3 REIMAGINE 5 and REDEFINE 9 trials for once-weekly CagriSema (cagrilintide and semaglutide). In REIMAGINE 5, CagriSema demonstrated a weight loss of 12.4% compared to 9.1% for tirzepatide, while in REDEFINE 9, it achieved a weight reduction of 21.0% versus 2.0% for placebo. The results support CagriSema&#39;s potential as a treatment for obesity and type 2 diabetes, with a New Drug Application filed with the FDA in December 2025 and a decision expected in Q4 2026.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NNE:1789988216181</loc>
    <lastmod>2026-09-21T10:56:56.181Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NNE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Needham Initiates Coverage On Nano Nuclear Energy with Buy Rating, Announces Price Target of $33</image:title>
      <image:caption>Needham analyst Sean Milligan has initiated coverage on Nano Nuclear Energy (NASDAQ: NNE) with a Buy rating. The analyst has set a price target of $33 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CRML:1789988126175</loc>
    <lastmod>2026-09-21T10:55:26.175Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/21/Tensions-Escalate-Between-the-US-and-EU.jpg?width=250&amp;height=187</image:loc>
      <image:title>Why Is Critical Metals Stock Soaring Monday?</image:title>
      <image:caption>Critical Metals Corp. (NASDAQ: CRML) stock surged approximately 27% in premarket trading, reaching $8.55, following a U.S.-Denmark agreement that enhances U.S. control over Greenland&#39;s security and highlights its strategic mineral resources. The company is developing the Tanbreez rare earth project in Greenland, which has drawn investor attention due to the potential for increased U.S. involvement in mining and infrastructure on the island. Other Greenland-related stocks also experienced gains as interest in strategically important minerals rises.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GE:1789987970555</loc>
    <lastmod>2026-09-21T10:52:50.555Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>GE Aerospace Announces $225M Investment To Modernize Its Research Center In Niskayuna, New York</image:title>
      <image:caption>GE Aerospace has announced a $225 million investment aimed at modernizing its research center located in Niskayuna, New York. This investment is part of the company&#39;s strategy to enhance its technological capabilities and innovation in aerospace. The move is expected to bolster GE Aerospace&#39;s position in the market and improve its research and development efforts.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CADL:1789987719912</loc>
    <lastmod>2026-09-21T10:48:39.912Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CADL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>B of A Securities Upgrades Candel Therapeutics to Buy, Raises Price Target to $18</image:title>
      <image:caption>B of A Securities has upgraded Candel Therapeutics (NASDAQ: CADL) from Neutral to Buy. The price target for the stock has been raised from $12 to $18.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MRK:1789987675602</loc>
    <lastmod>2026-09-21T10:47:55.602Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MRK/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Merck&amp;#39;s Subcutaneous KEYTRUDA QLEX Approved In Japan For All Existing KEYTRUDA Indications</image:title>
      <image:caption>Merck&#39;s KEYTRUDA QLEX has received approval from Japan&#39;s Ministry of Health, Labor and Welfare for subcutaneous use across all existing KEYTRUDA indications. This marks it as the first and only subcutaneous immune checkpoint inhibitor in Japan, allowing administration by healthcare providers in as little as one minute. The product, branded as KEYJECT in Japan, can be administered every three weeks or every six weeks, depending on the dosage schedule.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/UTSI:1789987479821</loc>
    <lastmod>2026-09-21T10:44:39.821Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/UTSI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UTStarcom Made Its Inaugural Appearance At China International Optoelectronic Exposition, Highlighting Its Optical Networking Expertise And Unveiling Concept Prototypes Of Its Next-Generation Optical Circuit Switching Platform Designed Specifically For AI Data Center Networking Infrastructure</image:title>
      <image:caption>UTStarcom Holdings Corp. made its debut at the China International Optoelectronic Exposition (CIOE 2026) from September 9-11, showcasing its optical networking expertise and unveiling concept prototypes of its next-generation Optical Circuit Switching (OCS) platform aimed at AI data center networking. The OCS solutions are designed to enhance AI cluster performance, reduce capital and operational expenditures, and provide scalable optical channels. The company presented two prototypes, UOS64 based on Silicon Photonics and MOS64 based on MEMS technology, alongside its software management ecosystem. Executives emphasized the importance of adapting networking strategies to meet the demands of AI infrastructure growth.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/EWTX:1789987396906</loc>
    <lastmod>2026-09-21T10:43:16.906Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/EWTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>HC Wainwright &amp;amp; Co. Maintains Buy on Edgewise Therapeutics, Raises Price Target to $57</image:title>
      <image:caption>HC Wainwright &amp; Co. analyst Lander Egaña Gorroño has maintained a Buy rating on Edgewise Therapeutics (NASDAQ: EWTX) and increased the price target from $45 to $57.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AVTR:1789987038289</loc>
    <lastmod>2026-09-21T10:37:18.289Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AVTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Avantor Appoints Todd Garner as Executive Vice President and CFO, Effective Immediately</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BKH:1789987028608</loc>
    <lastmod>2026-09-21T10:37:08.608Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BKH/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>B of A Securities Maintains Buy on Black Hills, Raises Price Target to $97</image:title>
      <image:caption>B of A Securities analyst Ross Fowler has maintained a Buy rating on Black Hills (NYSE: BKH) and raised the price target from $87 to $97. This reflects a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ENRD:1789987014017</loc>
    <lastmod>2026-09-21T10:36:54.017Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ENRD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Einride AB Collaborates With NVIDIA To Further Accelerate Transition Of Its Extensive Freight Network To Autonomous Operations</image:title>
      <image:caption>Einride AB has announced a strategic collaboration with NVIDIA to enhance its transition to autonomous operations within its freight network. The partnership will involve adapting the NVIDIA DRIVE Hyperion platform for heavy-duty trucking, allowing Einride to scale its autonomous deployment across its existing freight network. Currently, Einride operates hundreds of electric trucks and plans to expand its fleet to 1,500-2,000 vehicles by 2028, with approximately 80% of customer demand being suitable for automation.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/OSTX:1789986979827</loc>
    <lastmod>2026-09-21T10:36:19.827Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OSTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>OS Therapies Provided an Update on Global Early Market Access Regulatory Coordination Efforts By UK&amp;#39;s MHRA For OST-HER2 For Pulmonary Metastatic Osteosarcoma Under Project Orbis</image:title>
      <image:caption>OS Therapies announced alignment with the UK&#39;s MHRA to initiate a confirmatory Phase 3 trial for OST-HER2 in pulmonary metastatic osteosarcoma, with a Conditional Marketing Authorisation Application (CMAA) expected in the coming weeks and trial initiation planned for mid Q4 2026. The MHRA&#39;s recommendations include leading global regulatory efforts alongside the U.S. FDA and EMA, and access to the UK Clinical Practice Research Datalink to enhance data comparability. The company is also engaging with the U.S. FDA on alternative approval routes, while awaiting decisions on various regulatory designations ahead of its ongoing BLA filing completion in Q4 2026.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SSMR:1789986928195</loc>
    <lastmod>2026-09-21T10:35:28.195Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SSMR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Sunshine Silver Mining Expands Consolidated Mineral Rights Position In Idaho&amp;#39;s Silver Valley By ~14,100 Acres, Or 60%, To ~38,000 Acres</image:title>
      <image:caption>Sunshine Silver Mining &amp; Refining Company (NYSE: SSMR) has expanded its consolidated mineral rights position in Idaho&#39;s Silver Valley by approximately 14,100 acres, increasing its total holdings to around 38,000 acres, a 60% increase. The company, now the largest mineral rights holder in the Silver Valley, is launching a multi-year, 45,000-meter surface exploration drilling program targeting three areas: East Sunshine, Rock Creek, and Pine Creek, with drilling expected to commence in the fourth quarter of this year.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/VFS:1789986859971</loc>
    <lastmod>2026-09-21T10:34:19.971Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VFS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>VinFast Officially Opens Sales Of 2027 VF 8 To US Market, Featuring Key Upgrades In Technology, Safety, And Equipment To Deliver Refined Driving Experience</image:title>
      <image:caption>VinFast has officially launched sales of the 2027 VF 8 in the U.S. market, featuring significant upgrades in technology, safety, and equipment. The vehicle will be available for purchase starting September 2026 at authorized dealerships in major cities such as Chicago, Orlando, and San Diego, with pricing set at $40,400 for the ECO trim and $45,600 for the PLUS trim. The company is also offering competitive financing options, including 0% APR for up to 84 months, as part of its commitment to customer satisfaction and growth in North America.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ALNY:1789986857049</loc>
    <lastmod>2026-09-21T10:34:17.049Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ALNY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>HC Wainwright &amp;amp; Co. Reiterates Buy on Alnylam Pharmaceuticals, Maintains $455 Price Target</image:title>
      <image:caption>HC Wainwright &amp; Co. analyst Patrick R. Trucchio has reiterated a Buy rating on Alnylam Pharmaceuticals (NASDAQ: ALNY) and maintained a price target of $455 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MDA:1789986560016</loc>
    <lastmod>2026-09-21T10:29:20.016Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>MDA Space Announces TSX Approval To Repurchase 8,106,539 Shares</image:title>
      <image:caption>MDA Space has received approval from the TSX to repurchase up to 8,106,539 common shares, representing approximately 5% of its outstanding shares as of September 11, 2026. The share repurchase program, which will commence on September 23, 2026, and conclude on September 22, 2027, will allow purchases at market price through TSX facilities. MDA Space has also established an automatic share purchase plan with its broker to facilitate these repurchases, which will be conducted in accordance with TSX rules.</image:caption>
    </image:image>
  </url>
</urlset>